CARETRIM

This brand name is authorized in Nigeria.

Active ingredients

The drug CARETRIM contains a combination of these active pharmaceutical ingredients (APIs):

1	Sulfamethoxazole UNII JE42381TNV - SULFAMETHOXAZOLE
	Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis.
	Read more about Sulfamethoxazole
2	Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM
	Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells.
	Read more about Trimethoprim

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0213	Tablet	Caretrim TAB 400 mg; 80 mg 1000tablets	53 RNW-PP-311109 Caretrim CO-TRIMOXAZOLE Trimethoprim 80mg/sulfamethoxazole400mg A4-0213 Drugs Nigerian Products 1000tablets POM 1 4/17/2023 DIZPHARM (NIGERIA) LIMITED, NO 21/23 WAREHOUSE ROAD APAPA 8187494741 hello@dizpharm.org Dizpharm Nigeira Limited, KM 10, Ibusa-Asaba Expressway, Ibusa, Delta State, Nigeria	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01EE01	Sulfamethoxazole and trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
Discover more medicines within J01EE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0213